308 related articles for article (PubMed ID: 29796119)
1. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
2. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
3. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
Su Y; Fang H; Jiang F
Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
[TBL] [Abstract][Full Text] [Related]
4. MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles.
Yu M; Carter KT; Makar KW; Vickers K; Ulrich CM; Schoen RE; Brenner D; Markowitz SD; Grady WM
Epigenetics; 2015; 10(9):803-9. PubMed ID: 26186366
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
[TBL] [Abstract][Full Text] [Related]
6. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
8. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
9. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation Analysis Using Droplet Digital PCR.
Yu M; Heinzerling TJ; Grady WM
Methods Mol Biol; 2018; 1768():363-383. PubMed ID: 29717454
[TBL] [Abstract][Full Text] [Related]
11. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
[TBL] [Abstract][Full Text] [Related]
12. DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.
Hubers AJ; Heideman DA; Burgers SA; Herder GJ; Sterk PJ; Rhodius RJ; Smit HJ; Krouwels F; Welling A; Witte BI; Duin S; Koning R; Comans EF; Steenbergen RD; Postmus PE; Meijer GA; Snijders PJ; Smit EF; Thunnissen E
Br J Cancer; 2015 Mar; 112(6):1105-13. PubMed ID: 25719833
[TBL] [Abstract][Full Text] [Related]
13. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
14. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
[TBL] [Abstract][Full Text] [Related]
15. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.
Hubers AJ; Brinkman P; Boksem RJ; Rhodius RJ; Witte BI; Zwinderman AH; Heideman DA; Duin S; Koning R; Steenbergen RD; Snijders PJ; Smit EF; Sterk PJ; Thunnissen E
J Clin Pathol; 2014 Aug; 67(8):707-11. PubMed ID: 24915850
[TBL] [Abstract][Full Text] [Related]
16. Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis.
Su J; Liao J; Gao L; Shen J; Guarnera MA; Zhan M; Fang H; Stass SA; Jiang F
Oncotarget; 2016 Feb; 7(5):5131-42. PubMed ID: 26246471
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA.
Yang Z; Qi W; Sun L; Zhou H; Zhou B; Hu Y
Adv Clin Exp Med; 2019 Mar; 28(3):355-360. PubMed ID: 30516882
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
19. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
[TBL] [Abstract][Full Text] [Related]
20. Urine cell-based DNA methylation classifier for monitoring bladder cancer.
van der Heijden AG; Mengual L; Ingelmo-Torres M; Lozano JJ; van Rijt-van de Westerlo CCM; Baixauli M; Geavlete B; Moldoveanud C; Ene C; Dinney CP; Czerniak B; Schalken JA; Kiemeney LALM; Ribal MJ; Witjes JA; Alcaraz A
Clin Epigenetics; 2018; 10():71. PubMed ID: 29854012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]